Table 5.

Indications for MCS therapy for patients undergoing VA ECMO with unloading via Impella versus IABP.

Parameter	ECMO + IMPELLA (n=19)	ECMO + IABP (n=16)	p-value
Indication for ECLS
Acute myocardial infarction	7 (37)	5 (31)	0.73
Ischemic cardiomyopathy	4 (21)	0	0.11
Non-ischemic cardiomyopathy	3 (16)	2 (13)	1.00
Myocarditis	3 (16)	1 (6)	0.61
Post-cardiotomy shock	0	7 (44)	0.002
Post-transplant graft dysfunction	2 (11)	1 (6)	1.00
ECPR	5 (26)	0	0.027
Bridge to ventricular assist device	1 (5)	2 (13)	0.58
Bridge to heart transplant	1 (5)	1 (6)	1.00
Duration of VA-ECMO support, days	6.68 ± 4.52	6.19 ± 5.17	0.76
Peripheral cannulation strategy	16 (84)	8 (50)	0.065
Need for additional LV vent	0	4 (25)	0.035

Values presented as number (percentage) or mean ± standard deviation.